$4.17
0.60% today
Nasdaq, Aug 12, 07:46 pm CET
ISIN
US6821431029
Symbol
OMER

Omeros Corporation Stock price

$4.14
+0.49 13.42% 1M
-4.58 52.52% 6M
-5.74 58.10% YTD
-0.14 3.27% 1Y
-3.06 42.50% 3Y
-11.75 73.95% 5Y
-10.29 71.31% 10Y
-4.59 52.58% 20Y
Nasdaq, Closing price Mon, Aug 11 2025
+0.08 1.97%
ISIN
US6821431029
Symbol
OMER
Industry

Key metrics

Basic
Market capitalization
$277.9m
Enterprise Value
$622.5m
Net debt
$344.6m
Cash
$52.4m
Shares outstanding
58.1m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
- | 83.2
EV/Sales
- | 186.3
EV/FCF
negative
P/B
negative
Financial Health
Equity Ratio
-65.9%
Return on Equity
86.0%
ROCE
-108.6%
ROIC
-
Debt/Equity
-1.9
Financials (TTM | estimate)
Revenue
$0.0 | $3.3m
EBITDA
$-164.0m | $-43.2m
EBIT
$-165.0m | $-141.2m
Net Income
$-153.1m | $-113.4m
Free Cash Flow
$-142.8m
Growth (TTM | estimate)
Revenue
- | -
EBITDA
-0.8% | 74.3%
EBIT
-0.8% | 16.5%
Net Income
-26.4% | 27.8%
Free Cash Flow
-0.3%
Margin (TTM | estimate)
Gross
-
EBITDA
- | -1,293.6%
EBIT
-
Net
- | -3,393.6%
Free Cash Flow
-
More
EPS
$-2.6
FCF per Share
$-2.5
Short interest
24.3%
Employees
202
Rev per Employee
$0.0
Show more

Is Omeros Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.

Omeros Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

11 Analysts have issued a Omeros Corporation forecast:

8x Buy
73%
3x Hold
27%

Analyst Opinions

11 Analysts have issued a Omeros Corporation forecast:

Buy
73%
Hold
27%

Financial data from Omeros Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 49 49
4% 4%
-
- Research and Development Expense 117 117
0% 0%
-
-164 -164
1% 1%
-
- Depreciation and Amortization 1.04 1.04
12% 12%
-
EBIT (Operating Income) EBIT -165 -165
1% 1%
-
Net Profit -153 -153
26% 26%
-

In millions USD.

Don't miss a Thing! We will send you all news about Omeros Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Omeros Corporation Stock News

Neutral
Business Wire
about 22 hours ago
SEATTLE--(BUSINESS WIRE)--Omeros Corporation (NASDAQ: OMER), today announced that the company will issue its financial results for the quarter ended June 30, 2025, on Thursday, August 14, 2025, after the market closes. Omeros management will host a conference call and webcast that same day at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss the financial results as well as recent deve...
Neutral
Business Wire
18 days ago
SEATTLE--(BUSINESS WIRE)--Omeros Corporation (Nasdaq: OMER) (“Omeros” or the “Company”) announced that on July 24, 2025 it entered into a securities purchase agreement with Polar Asset Management Partners to sell approximately $22 million of its common stock in a registered direct offering. Under the terms of the securities purchase agreement, the Company has agreed to sell 5,365,853 shares of ...
Neutral
Business Wire
about 2 months ago
SEATTLE--(BUSINESS WIRE)--Omeros Corporation (Nasdaq: OMER) today announced the recent submission of a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for narsoplimab for the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy (TA-TMA). The MAA includes response-based analyses in narsoplimab-treated TA-TMA patients as well as an...
More Omeros Corporation News

Company Profile

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializes of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Head office United States
CEO Gregory Demopulos
Employees 202
Founded 1994
Website www.omeros.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today